Prescription opioid use among women of reproductive age in the United States: NHANES, 2003–2018

Elmore, Amanda L.; Omofuma, Omonefe O.; Sevoyan, Maria; Richard, Chelsea L; Liu, Jihong

doi:10.1016/j.ypmed.2021.106846

Cited by 8 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…'"; "People look at you like you're the worst mother in the world." Many patients report negative experiences with the healthcare system due to stigma [26,27] . If we are open and suspend judgement, space for hopes and dreams can be created.…”

Section: Deconstructing and Addressing Stigmamentioning

confidence: 99%

Understanding Addiction in the Context of Perinatal Substance Use: A Reflection for Clinicians

2023

IJFMR

View full text Add to dashboard Cite

Society determines what substances are legal and not, and some people can use a variety of substances without negative consequences. Substance use occurs on a continuum from use to harmful use, to addiction [1,2]. It is important that support and treatment take into consideration the complex pathways, consequences and outcomes of substance use, harmful use, and addiction [4]. Perinatal harm reduction focuses on building relationships to empower women with knowledge about the harms associated with substance use when pregnant, and choice about the type and extent of change she wishes to make [3,5]. The medical model explains 'addiction' as a treatable disease which is helpful in removing stigma and explaining how physiology can affect behaviour [6]. It helps women and families associate problematic substance use with substance use disorder and not as a weakness of the person. Substance use disorder is commonly rooted in childhood trauma, stressors, feelings of shame or 'less than'[1,3,6]. Building on recovery capital when women are inspired during pregnancy and postpartum can be an opportunity for change, growth, healing, and empowerment. Humans are complex biopsychosocial and spiritual beings, so the treatment, recovery, and healing require a holistic approach. This does not mean you need a big team… just time, trust, and patience... and a commitment to support change![8]

show abstract

Section: Deconstructing and Addressing Stigmamentioning

confidence: 99%

Understanding Addiction in the Context of Perinatal Substance Use: A Reflection for Clinicians

2023

IJFMR

View full text Add to dashboard Cite

show abstract

“…Substance misuse during pregnancy can result in poor pregnancy outcomes, including miscarriage, preterm birth, low birthweight, birth defects, and developmental delays [1,2]. The most common substances used during pregnancy are tobacco, ethanol, and cannabis, with ethanol being the substance most associated with facial dysmorphisms and alterations to central nervous system development [3][4][5]. Objective data reporting the prevalence of neonates born with ethanol metabolites (evidence of prenatal ethanol exposure) in their system is limited.…”

Section: Introductionmentioning

confidence: 99%

Using umbilical cord tissue to identify prenatal ethanol exposure and co-exposure to other commonly misused substances

Jones,

Coy,

Gidron

et al. 2024

J Perinatol

View full text Add to dashboard Cite

Objective Substance misuse during pregnancy can result in a variety of poor pregnancy outcomes. Objective data reporting the prevalence of neonates born with ethanol metabolites (evidence of prenatal ethanol exposure) in their fluids or tissues are limited. Study design A secondary analysis of umbilical cord tissue specimens received for routine toxicological analysis was conducted. Prevalences of ethyl glucuronide (EtG), a long-term direct ethanol biomarker, were determined using a new laboratory tool, LDTD-MSMS. Additionally, other commonly misused substances were determined using routine procedures. Results Of 12,995 specimens, 238 (1.8%) specimens contained EtG. Concentrations of EtG ranged from 5 ng/g to 6679 ng/g (median 47 ng/mg; IQR: 16 ng/g, 203 ng/g). Of those 238 EtG-positive specimens, nearly 58% (N = 138) contained additional substances or metabolites. Conclusion Self-report of substance use during pregnancy is under-reported. We have demonstrated co-exposure of substances with ethanol is higher than previous reports.

show abstract

Association between physical activity and depression in adult prescription opioid users: A cross-sectional analysis based on NHANES 2007–2018

Li,

Ji,

Jiang

et al. 2024

General Hospital Psychiatry

View full text Add to dashboard Cite

Prescription opioid use among women of reproductive age in the United States: NHANES, 2003–2018

Cited by 8 publications

References 28 publications

Understanding Addiction in the Context of Perinatal Substance Use: A Reflection for Clinicians

Understanding Addiction in the Context of Perinatal Substance Use: A Reflection for Clinicians

Using umbilical cord tissue to identify prenatal ethanol exposure and co-exposure to other commonly misused substances

Association between physical activity and depression in adult prescription opioid users: A cross-sectional analysis based on NHANES 2007–2018

Contact Info

Product

Resources

About